Previous product
Back to products
Qinlock (ripretinib)
CHF50,700.00
Next product
Stivarga (regorafenib)
CHF3,965.00
Kadcyla (trastuzumab emtansine)
CHF3,444.22
Kadcyla (trastuzumab emtansine) is a cancer medicine that is used to treat advanced or metastatic HER2-positive breast cancer (cancer that has spread to other parts of the body) in adults who previously received trastuzumab and a taxane.
Reviews
There are no reviews yet.